Company: FLDDW
Filing Date: 2025-08-11
Form Type: 424B3
Source: 0001213900-25-074298
Chunk: 109

Company: Fold Holdings, Inc.
Filing Date: 2025-08-11
Form: 424B3
Chunk 109
---
 aggregated with all other Shares then beneficially owned by SZOP and its affiliates (as calculated pursuant to Section 13(d) of the Exchange Act, and Rule 13d -3promulgated thereunder), would result in the beneficial ownership by SZOP and its affiliates to exceed 9.99% of the outstanding voting power or number of the Common Stock. As of July8, 2025, SZOP beneficially owned no shares of our Common Stock. The Facility contains customary representations, warranties, conditions and indemnification obligations of the parties. The representations, warranties and covenants contained in such agreement were made only for purposes of such agreements and as of specific dates, were solely for the benefit of the parties to such agreement and may be subject to limitations agreed upon by the contracting parties. Cohen & Company Securities, LLC (“Cohen”) acted as the placement agent in connection with the transactions contemplated by the Facility, for which the Company has agreed to issue 75,000shares of Common Stock to Cohen at the time of the placement of the Facility in connection with the placement of the Facility (such shares, the “Placement Shares”), and to pay customary placement fees and reimburse certain expenses of Cohen. The Company cannot effect any sales under the Facility and SZOP will not have any obligation to purchase Advance Shares under the Facility to the extent that after giving effect to such purchase and sale the aggregate number of Advance Shares issued under the Facility together with any shares of Common Stock issued in connection with any other transaction that may be considered part of the same series of transactions, where the number of shares issued 59 would exceed the number of shares representing 19.99% of the issued and outstanding shares of Common Stock as of the date of the Facility (the “Exchange Cap”), unless the Company has obtained stockholder approval as required for issuance of Common Stock in excess of the Exchange Cap, in accordance with the applicable rules of Nasdaq. Accordingly, the Company may not have access to the right to sell the full Commitment to SZOP. As of June 15, 2025, there were 46,434,655shares of Common Stock outstanding, and therefore the Exchange Cap is 9,282,287shares of Common Stock. In connection with the Facility, the Company is registering for resale up to 9,282,287shares of Common Stock under this prospectus, which represents the maximum number of shares of Common Stock that it could register without obtaining stockholder approval. There are substantial risks to the Company’s stockholders as